These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

501 related articles for article (PubMed ID: 24289328)

  • 1. Aberrant methylation of NPY, PENK, and WIF1 as a promising marker for blood-based diagnosis of colorectal cancer.
    Roperch JP; Incitti R; Forbin S; Bard F; Mansour H; Mesli F; Baumgaertner I; Brunetti F; Sobhani I
    BMC Cancer; 2013 Dec; 13():566. PubMed ID: 24289328
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The detection of specific hypermethylated WIF1 and NPY genes in circulating DNA by crystal digital PCR™ is a powerful new tool for colorectal cancer diagnosis and screening.
    Overs A; Flammang M; Hervouet E; Bermont L; Pretet JL; Christophe B; Selmani Z
    BMC Cancer; 2021 Oct; 21(1):1092. PubMed ID: 34627187
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of promoter hypermethylation of Wnt antagonist genes in fecal samples for diagnosis of early colorectal cancer.
    Zhang H; Zhu YQ; Wu YQ; Zhang P; Qi J
    World J Gastroenterol; 2014 May; 20(20):6329-35. PubMed ID: 24876755
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aberrant promoter methylation of PPP1R3C and EFHD1 in plasma of colorectal cancer patients.
    Takane K; Midorikawa Y; Yagi K; Sakai A; Aburatani H; Takayama T; Kaneda A
    Cancer Med; 2014 Oct; 3(5):1235-45. PubMed ID: 24861485
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Study of Hypermethylated Circulating Tumor DNA as a Universal Colorectal Cancer Biomarker.
    Garrigou S; Perkins G; Garlan F; Normand C; Didelot A; Le Corre D; Peyvandi S; Mulot C; Niarra R; Aucouturier P; Chatellier G; Nizard P; Perez-Toralla K; Zonta E; Charpy C; Pujals A; Barau C; Bouché O; Emile JF; Pezet D; Bibeau F; Hutchison JB; Link DR; Zaanan A; Laurent-Puig P; Sobhani I; Taly V
    Clin Chem; 2016 Aug; 62(8):1129-39. PubMed ID: 27251038
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Usefulness of plasma epigenetic changes of five major genes involved in the pathogenesis of colorectal cancer.
    Pack SC; Kim HR; Lim SW; Kim HY; Ko JY; Lee KS; Hwang D; Park SI; Kang H; Park SW; Hong GY; Hwang SM; Shin MG; Lee S
    Int J Colorectal Dis; 2013 Jan; 28(1):139-47. PubMed ID: 22990173
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improved amplification efficiency on stool samples by addition of spermidine and its use for non-invasive detection of colorectal cancer.
    Roperch JP; Benzekri K; Mansour H; Incitti R
    BMC Biotechnol; 2015 May; 15():41. PubMed ID: 26022272
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel DNA methylation panel accurately detects colorectal cancer independently of molecular pathway.
    Freitas M; Ferreira F; Carvalho S; Silva F; Lopes P; Antunes L; Salta S; Diniz F; Santos LL; Videira JF; Henrique R; Jerónimo C
    J Transl Med; 2018 Feb; 16(1):45. PubMed ID: 29486770
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypermethylated DNA, a circulating biomarker for colorectal cancer detection.
    Rasmussen SL; Krarup HB; Sunesen KG; Johansen MB; Stender MT; Pedersen IS; Madsen PH; Thorlacius-Ussing O
    PLoS One; 2017; 12(7):e0180809. PubMed ID: 28700744
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Commonality and differences of methylation signatures in the plasma of patients with pancreatic cancer and colorectal cancer.
    Melson J; Li Y; Cassinotti E; Melnikov A; Boni L; Ai J; Greenspan M; Mobarhan S; Levenson V; Deng Y
    Int J Cancer; 2014 Jun; 134(11):2656-62. PubMed ID: 24288256
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genome-wide methylation profiling identified novel differentially hypermethylated biomarker MPPED2 in colorectal cancer.
    Gu S; Lin S; Ye D; Qian S; Jiang D; Zhang X; Li Q; Yang J; Ying X; Li Z; Tang M; Wang J; Jin M; Chen K
    Clin Epigenetics; 2019 Mar; 11(1):41. PubMed ID: 30846004
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Colorectal cancer-associated microbiota contributes to oncogenic epigenetic signatures.
    Sobhani I; Bergsten E; Couffin S; Amiot A; Nebbad B; Barau C; de'Angelis N; Rabot S; Canoui-Poitrine F; Mestivier D; Pédron T; Khazaie K; Sansonetti PJ
    Proc Natl Acad Sci U S A; 2019 Nov; 116(48):24285-24295. PubMed ID: 31712445
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A panel of genes methylated with high frequency in colorectal cancer.
    Mitchell SM; Ross JP; Drew HR; Ho T; Brown GS; Saunders NF; Duesing KR; Buckley MJ; Dunne R; Beetson I; Rand KN; McEvoy A; Thomas ML; Baker RT; Wattchow DA; Young GP; Lockett TJ; Pedersen SK; Lapointe LC; Molloy PL
    BMC Cancer; 2014 Jan; 14():54. PubMed ID: 24485021
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The detection of the methylated Wif-1 gene is more accurate than a fecal occult blood test for colorectal cancer screening.
    Amiot A; Mansour H; Baumgaertner I; Delchier JC; Tournigand C; Furet JP; Carrau JP; Canoui-Poitrine F; Sobhani I;
    PLoS One; 2014; 9(7):e99233. PubMed ID: 25025467
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative analysis of PCR-based biomarker assay methods for colorectal polyp detection from fecal DNA.
    Ausch C; Kim YH; Tsuchiya KD; Dzieciatkowski S; Washington MK; Paraskeva C; Radich J; Grady WM
    Clin Chem; 2009 Aug; 55(8):1559-63. PubMed ID: 19541867
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical Relevance of Plasma DNA Methylation in Colorectal Cancer Patients Identified by Using a Genome-Wide High-Resolution Array.
    Lin PC; Lin JK; Lin CH; Lin HH; Yang SH; Jiang JK; Chen WS; Chou CC; Tsai SF; Chang SC
    Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1419-27. PubMed ID: 25472652
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aging related methylation influences the gene expression of key control genes in colorectal cancer and adenoma.
    Galamb O; Kalmár A; Barták BK; Patai ÁV; Leiszter K; Péterfia B; Wichmann B; Valcz G; Veres G; Tulassay Z; Molnár B
    World J Gastroenterol; 2016 Dec; 22(47):10325-10340. PubMed ID: 28058013
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel candidate colorectal cancer biomarkers identified by methylation microarray-based scanning.
    Mori Y; Olaru AV; Cheng Y; Agarwal R; Yang J; Luvsanjav D; Yu W; Selaru FM; Hutfless S; Lazarev M; Kwon JH; Brant SR; Marohn MR; Hutcheon DF; Duncan MD; Goel A; Meltzer SJ
    Endocr Relat Cancer; 2011 Aug; 18(4):465-78. PubMed ID: 21636702
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of DNA methylation markers for early detection of CRC indicates a role for nervous system-related genes in CRC.
    Rademakers G; Massen M; Koch A; Draht MX; Buekers N; Wouters KAD; Vaes N; De Meyer T; Carvalho B; Meijer GA; Herman JG; Smits KM; van Engeland M; Melotte V
    Clin Epigenetics; 2021 Apr; 13(1):80. PubMed ID: 33858496
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early detection of colorectal cancer based on presence of methylated syndecan-2 (SDC2) in stool DNA.
    Han YD; Oh TJ; Chung TH; Jang HW; Kim YN; An S; Kim NK
    Clin Epigenetics; 2019 Mar; 11(1):51. PubMed ID: 30876480
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.